SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-061526
Filing Date
2024-05-17
Accepted
2024-05-17 15:15:46
Documents
12
Period of Report
2024-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20240513.htm   iXBRL 8-K 43894
2 EX-10.1 rkda-ex10_1.htm EX-10.1 498948
  Complete submission text file 0000950170-24-061526.txt   705763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20240513.xsd EX-101.SCH 24851
15 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20240513_htm.xml XML 4671
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 24959220
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)